Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fleckenstein

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2020
3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine TransportersCharlotte P Magee, Christopher L German, Yasmeen H Siripathane, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicityJannine G Truong, Diana G Wilkins, Jakub Baudys, et al.
European Journal of Pharmacology|November 11, 1999
Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter functionA E Fleckenstein, H M Haughey, R R Metzger, et al.
JNCI Cancer Spectrum|May 5, 2025
Accuracy of self-reported exam indications for breast cancer screeningErin J Aiello Bowles, Hongyuan Gao, Lynn E Fleckenstein, et al.
Synapse (New York, N.Y.)|November 29, 2011
Methamphetamine self-administration acutely decreases monoaminergic transporter functionLisa M McFadden, Kristen A Stout, Paula L Vieira-Brock, et al.
Synapse (New York, N.Y.)|April 14, 2016
Sex differences in neurotensin and substance P following nicotine self-administration in ratsSteven T Pittenger, Natashia Swalve, Shinnyi Chou, et al.
Neuropharmacology|July 12, 2005
Bupropion increases striatal vesicular monoamine transportKristi S Rau, Elisabeth Birdsall, Jarom E Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2009
Mechanisms underlying methamphetamine-induced dopamine transporter complex formationGregory C Hadlock, Anthony J Baucum, Jill L King, et al.
Frontiers in Psychiatry|April 8, 2026
Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotypeAlexandru Mihai Dumitrescu, M Frances Vest, Annette E Fleckenstein, et al.
Synapse (New York, N.Y.)|January 23, 2016
An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicityAshley N Fricks-Gleason, Christopher L German, Amanda J Hoonakker, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2020
3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine TransportersCharlotte P Magee, Christopher L German, Yasmeen H Siripathane, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicityJannine G Truong, Diana G Wilkins, Jakub Baudys, et al.
European Journal of Pharmacology|November 11, 1999
Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter functionA E Fleckenstein, H M Haughey, R R Metzger, et al.
JNCI Cancer Spectrum|May 5, 2025
Accuracy of self-reported exam indications for breast cancer screeningErin J Aiello Bowles, Hongyuan Gao, Lynn E Fleckenstein, et al.
Synapse (New York, N.Y.)|November 29, 2011
Methamphetamine self-administration acutely decreases monoaminergic transporter functionLisa M McFadden, Kristen A Stout, Paula L Vieira-Brock, et al.
Synapse (New York, N.Y.)|April 14, 2016
Sex differences in neurotensin and substance P following nicotine self-administration in ratsSteven T Pittenger, Natashia Swalve, Shinnyi Chou, et al.
Neuropharmacology|July 12, 2005
Bupropion increases striatal vesicular monoamine transportKristi S Rau, Elisabeth Birdsall, Jarom E Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2009
Mechanisms underlying methamphetamine-induced dopamine transporter complex formationGregory C Hadlock, Anthony J Baucum, Jill L King, et al.
Frontiers in Psychiatry|April 8, 2026
Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotypeAlexandru Mihai Dumitrescu, M Frances Vest, Annette E Fleckenstein, et al.
Synapse (New York, N.Y.)|January 23, 2016
An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicityAshley N Fricks-Gleason, Christopher L German, Amanda J Hoonakker, et al.
Pageof 14